风湿免疫科

订阅

MedSci主页 / 所有栏目 / 风湿免疫科

2019年EULAR建议：成人抗磷脂综合征的管理

2021-11-05 张磊 岭南风湿

抗磷脂综合征
关注

抗磷脂综合征是以抗磷脂抗体持续阳性、复发性的静脉或动脉血栓、习惯性流产和血小板减少症为特征的非炎性自身免疫性疾病。

 

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1203280, encodeId=3f0b1203280d6, content=学习了，非常感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b10a5123387, createdName=陈宪, createdTime=Wed Mar 16 22:47:00 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200245, encodeId=6d3312002454f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19a85577025, createdName=曾曾曾, createdTime=Mon Mar 07 15:52:55 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183846, encodeId=ef27118384638, content=感谢分享，大牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLPVlsekolw6geYQia4ibhibRsoaicSNwj85vxpvGKy4NVeFEAOw93Fpe5alWicWvia2ibVqlMlqkJ6Qnd7w/0, createdBy=b5442227668, createdName=单车, createdTime=Thu Jan 13 11:41:32 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075000, encodeId=3bf810e5000a3, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201127/23ff6f9b0b4d457488c4243a3bb0edac/c3674632650e47e5b3388daeb6015846.jpg, createdBy=7c7a5437558, createdName=ms4000002005061674, createdTime=Mon Nov 29 10:13:32 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1432183, encodeId=77a01432183ae, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sun Nov 07 07:56:46 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1455361, encodeId=5fae145536121, content=<a href='/topic/show?id=4272e0771a' target=_blank style='color:#2F92EE;'>#EULAR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7077, encryptionId=4272e0771a, topicName=EULAR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f855654200, createdName=muzishouyi, createdTime=Sun Nov 07 07:56:46 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067401, encodeId=69d8106e40178, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e99c5694546, createdName=ms3000001989507817, createdTime=Fri Nov 05 21:14:57 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067386, encodeId=e131106e3861b, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>、很好的`冂内容，学]习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1e52476457, createdName=1244b6b8m85(暂无昵称), createdTime=Fri Nov 05 20:07:28 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067351, encodeId=7968106e3519e, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644b2182796, createdName=1207866fm50(暂无昵称), createdTime=Fri Nov 05 18:52:21 CST 2021, time=2021-11-05, status=1, ipAttribution=)]
    2022-03-16 陈宪

    学习了，非常感谢

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1203280, encodeId=3f0b1203280d6, content=学习了，非常感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b10a5123387, createdName=陈宪, createdTime=Wed Mar 16 22:47:00 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200245, encodeId=6d3312002454f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19a85577025, createdName=曾曾曾, createdTime=Mon Mar 07 15:52:55 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183846, encodeId=ef27118384638, content=感谢分享，大牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLPVlsekolw6geYQia4ibhibRsoaicSNwj85vxpvGKy4NVeFEAOw93Fpe5alWicWvia2ibVqlMlqkJ6Qnd7w/0, createdBy=b5442227668, createdName=单车, createdTime=Thu Jan 13 11:41:32 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075000, encodeId=3bf810e5000a3, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201127/23ff6f9b0b4d457488c4243a3bb0edac/c3674632650e47e5b3388daeb6015846.jpg, createdBy=7c7a5437558, createdName=ms4000002005061674, createdTime=Mon Nov 29 10:13:32 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1432183, encodeId=77a01432183ae, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sun Nov 07 07:56:46 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1455361, encodeId=5fae145536121, content=<a href='/topic/show?id=4272e0771a' target=_blank style='color:#2F92EE;'>#EULAR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7077, encryptionId=4272e0771a, topicName=EULAR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f855654200, createdName=muzishouyi, createdTime=Sun Nov 07 07:56:46 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067401, encodeId=69d8106e40178, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e99c5694546, createdName=ms3000001989507817, createdTime=Fri Nov 05 21:14:57 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067386, encodeId=e131106e3861b, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>、很好的`冂内容，学]习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1e52476457, createdName=1244b6b8m85(暂无昵称), createdTime=Fri Nov 05 20:07:28 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067351, encodeId=7968106e3519e, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644b2182796, createdName=1207866fm50(暂无昵称), createdTime=Fri Nov 05 18:52:21 CST 2021, time=2021-11-05, status=1, ipAttribution=)]
    2022-03-07 曾曾曾

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1203280, encodeId=3f0b1203280d6, content=学习了，非常感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b10a5123387, createdName=陈宪, createdTime=Wed Mar 16 22:47:00 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200245, encodeId=6d3312002454f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19a85577025, createdName=曾曾曾, createdTime=Mon Mar 07 15:52:55 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183846, encodeId=ef27118384638, content=感谢分享，大牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLPVlsekolw6geYQia4ibhibRsoaicSNwj85vxpvGKy4NVeFEAOw93Fpe5alWicWvia2ibVqlMlqkJ6Qnd7w/0, createdBy=b5442227668, createdName=单车, createdTime=Thu Jan 13 11:41:32 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075000, encodeId=3bf810e5000a3, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201127/23ff6f9b0b4d457488c4243a3bb0edac/c3674632650e47e5b3388daeb6015846.jpg, createdBy=7c7a5437558, createdName=ms4000002005061674, createdTime=Mon Nov 29 10:13:32 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1432183, encodeId=77a01432183ae, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sun Nov 07 07:56:46 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1455361, encodeId=5fae145536121, content=<a href='/topic/show?id=4272e0771a' target=_blank style='color:#2F92EE;'>#EULAR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7077, encryptionId=4272e0771a, topicName=EULAR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f855654200, createdName=muzishouyi, createdTime=Sun Nov 07 07:56:46 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067401, encodeId=69d8106e40178, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e99c5694546, createdName=ms3000001989507817, createdTime=Fri Nov 05 21:14:57 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067386, encodeId=e131106e3861b, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>、很好的`冂内容，学]习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1e52476457, createdName=1244b6b8m85(暂无昵称), createdTime=Fri Nov 05 20:07:28 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067351, encodeId=7968106e3519e, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644b2182796, createdName=1207866fm50(暂无昵称), createdTime=Fri Nov 05 18:52:21 CST 2021, time=2021-11-05, status=1, ipAttribution=)]
    2022-01-13 单车

    感谢分享，大牛

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1203280, encodeId=3f0b1203280d6, content=学习了，非常感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b10a5123387, createdName=陈宪, createdTime=Wed Mar 16 22:47:00 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200245, encodeId=6d3312002454f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19a85577025, createdName=曾曾曾, createdTime=Mon Mar 07 15:52:55 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183846, encodeId=ef27118384638, content=感谢分享，大牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLPVlsekolw6geYQia4ibhibRsoaicSNwj85vxpvGKy4NVeFEAOw93Fpe5alWicWvia2ibVqlMlqkJ6Qnd7w/0, createdBy=b5442227668, createdName=单车, createdTime=Thu Jan 13 11:41:32 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075000, encodeId=3bf810e5000a3, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201127/23ff6f9b0b4d457488c4243a3bb0edac/c3674632650e47e5b3388daeb6015846.jpg, createdBy=7c7a5437558, createdName=ms4000002005061674, createdTime=Mon Nov 29 10:13:32 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1432183, encodeId=77a01432183ae, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sun Nov 07 07:56:46 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1455361, encodeId=5fae145536121, content=<a href='/topic/show?id=4272e0771a' target=_blank style='color:#2F92EE;'>#EULAR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7077, encryptionId=4272e0771a, topicName=EULAR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f855654200, createdName=muzishouyi, createdTime=Sun Nov 07 07:56:46 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067401, encodeId=69d8106e40178, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e99c5694546, createdName=ms3000001989507817, createdTime=Fri Nov 05 21:14:57 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067386, encodeId=e131106e3861b, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>、很好的`冂内容，学]习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1e52476457, createdName=1244b6b8m85(暂无昵称), createdTime=Fri Nov 05 20:07:28 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067351, encodeId=7968106e3519e, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644b2182796, createdName=1207866fm50(暂无昵称), createdTime=Fri Nov 05 18:52:21 CST 2021, time=2021-11-05, status=1, ipAttribution=)]
    2021-11-29 ms4000002005061674

    感谢分享

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1203280, encodeId=3f0b1203280d6, content=学习了，非常感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b10a5123387, createdName=陈宪, createdTime=Wed Mar 16 22:47:00 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200245, encodeId=6d3312002454f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19a85577025, createdName=曾曾曾, createdTime=Mon Mar 07 15:52:55 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183846, encodeId=ef27118384638, content=感谢分享，大牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLPVlsekolw6geYQia4ibhibRsoaicSNwj85vxpvGKy4NVeFEAOw93Fpe5alWicWvia2ibVqlMlqkJ6Qnd7w/0, createdBy=b5442227668, createdName=单车, createdTime=Thu Jan 13 11:41:32 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075000, encodeId=3bf810e5000a3, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201127/23ff6f9b0b4d457488c4243a3bb0edac/c3674632650e47e5b3388daeb6015846.jpg, createdBy=7c7a5437558, createdName=ms4000002005061674, createdTime=Mon Nov 29 10:13:32 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1432183, encodeId=77a01432183ae, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sun Nov 07 07:56:46 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1455361, encodeId=5fae145536121, content=<a href='/topic/show?id=4272e0771a' target=_blank style='color:#2F92EE;'>#EULAR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7077, encryptionId=4272e0771a, topicName=EULAR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f855654200, createdName=muzishouyi, createdTime=Sun Nov 07 07:56:46 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067401, encodeId=69d8106e40178, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e99c5694546, createdName=ms3000001989507817, createdTime=Fri Nov 05 21:14:57 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067386, encodeId=e131106e3861b, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>、很好的`冂内容，学]习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1e52476457, createdName=1244b6b8m85(暂无昵称), createdTime=Fri Nov 05 20:07:28 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067351, encodeId=7968106e3519e, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644b2182796, createdName=1207866fm50(暂无昵称), createdTime=Fri Nov 05 18:52:21 CST 2021, time=2021-11-05, status=1, ipAttribution=)]
    2021-11-07 zhouqu_8

    #综合征#

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1203280, encodeId=3f0b1203280d6, content=学习了，非常感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b10a5123387, createdName=陈宪, createdTime=Wed Mar 16 22:47:00 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200245, encodeId=6d3312002454f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19a85577025, createdName=曾曾曾, createdTime=Mon Mar 07 15:52:55 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183846, encodeId=ef27118384638, content=感谢分享，大牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLPVlsekolw6geYQia4ibhibRsoaicSNwj85vxpvGKy4NVeFEAOw93Fpe5alWicWvia2ibVqlMlqkJ6Qnd7w/0, createdBy=b5442227668, createdName=单车, createdTime=Thu Jan 13 11:41:32 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075000, encodeId=3bf810e5000a3, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201127/23ff6f9b0b4d457488c4243a3bb0edac/c3674632650e47e5b3388daeb6015846.jpg, createdBy=7c7a5437558, createdName=ms4000002005061674, createdTime=Mon Nov 29 10:13:32 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1432183, encodeId=77a01432183ae, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sun Nov 07 07:56:46 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1455361, encodeId=5fae145536121, content=<a href='/topic/show?id=4272e0771a' target=_blank style='color:#2F92EE;'>#EULAR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7077, encryptionId=4272e0771a, topicName=EULAR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f855654200, createdName=muzishouyi, createdTime=Sun Nov 07 07:56:46 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067401, encodeId=69d8106e40178, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e99c5694546, createdName=ms3000001989507817, createdTime=Fri Nov 05 21:14:57 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067386, encodeId=e131106e3861b, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>、很好的`冂内容，学]习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1e52476457, createdName=1244b6b8m85(暂无昵称), createdTime=Fri Nov 05 20:07:28 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067351, encodeId=7968106e3519e, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644b2182796, createdName=1207866fm50(暂无昵称), createdTime=Fri Nov 05 18:52:21 CST 2021, time=2021-11-05, status=1, ipAttribution=)]
    2021-11-07 muzishouyi

    #EULAR#

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1203280, encodeId=3f0b1203280d6, content=学习了，非常感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b10a5123387, createdName=陈宪, createdTime=Wed Mar 16 22:47:00 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200245, encodeId=6d3312002454f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19a85577025, createdName=曾曾曾, createdTime=Mon Mar 07 15:52:55 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183846, encodeId=ef27118384638, content=感谢分享，大牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLPVlsekolw6geYQia4ibhibRsoaicSNwj85vxpvGKy4NVeFEAOw93Fpe5alWicWvia2ibVqlMlqkJ6Qnd7w/0, createdBy=b5442227668, createdName=单车, createdTime=Thu Jan 13 11:41:32 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075000, encodeId=3bf810e5000a3, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201127/23ff6f9b0b4d457488c4243a3bb0edac/c3674632650e47e5b3388daeb6015846.jpg, createdBy=7c7a5437558, createdName=ms4000002005061674, createdTime=Mon Nov 29 10:13:32 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1432183, encodeId=77a01432183ae, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sun Nov 07 07:56:46 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1455361, encodeId=5fae145536121, content=<a href='/topic/show?id=4272e0771a' target=_blank style='color:#2F92EE;'>#EULAR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7077, encryptionId=4272e0771a, topicName=EULAR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f855654200, createdName=muzishouyi, createdTime=Sun Nov 07 07:56:46 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067401, encodeId=69d8106e40178, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e99c5694546, createdName=ms3000001989507817, createdTime=Fri Nov 05 21:14:57 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067386, encodeId=e131106e3861b, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>、很好的`冂内容，学]习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1e52476457, createdName=1244b6b8m85(暂无昵称), createdTime=Fri Nov 05 20:07:28 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067351, encodeId=7968106e3519e, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644b2182796, createdName=1207866fm50(暂无昵称), createdTime=Fri Nov 05 18:52:21 CST 2021, time=2021-11-05, status=1, ipAttribution=)]
    2021-11-05 ms3000001989507817

    谢谢分享

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1203280, encodeId=3f0b1203280d6, content=学习了，非常感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b10a5123387, createdName=陈宪, createdTime=Wed Mar 16 22:47:00 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200245, encodeId=6d3312002454f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19a85577025, createdName=曾曾曾, createdTime=Mon Mar 07 15:52:55 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183846, encodeId=ef27118384638, content=感谢分享，大牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLPVlsekolw6geYQia4ibhibRsoaicSNwj85vxpvGKy4NVeFEAOw93Fpe5alWicWvia2ibVqlMlqkJ6Qnd7w/0, createdBy=b5442227668, createdName=单车, createdTime=Thu Jan 13 11:41:32 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075000, encodeId=3bf810e5000a3, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201127/23ff6f9b0b4d457488c4243a3bb0edac/c3674632650e47e5b3388daeb6015846.jpg, createdBy=7c7a5437558, createdName=ms4000002005061674, createdTime=Mon Nov 29 10:13:32 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1432183, encodeId=77a01432183ae, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sun Nov 07 07:56:46 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1455361, encodeId=5fae145536121, content=<a href='/topic/show?id=4272e0771a' target=_blank style='color:#2F92EE;'>#EULAR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7077, encryptionId=4272e0771a, topicName=EULAR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f855654200, createdName=muzishouyi, createdTime=Sun Nov 07 07:56:46 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067401, encodeId=69d8106e40178, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e99c5694546, createdName=ms3000001989507817, createdTime=Fri Nov 05 21:14:57 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067386, encodeId=e131106e3861b, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>、很好的`冂内容，学]习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1e52476457, createdName=1244b6b8m85(暂无昵称), createdTime=Fri Nov 05 20:07:28 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067351, encodeId=7968106e3519e, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644b2182796, createdName=1207866fm50(暂无昵称), createdTime=Fri Nov 05 18:52:21 CST 2021, time=2021-11-05, status=1, ipAttribution=)]
    2021-11-05 1244b6b8m85(暂无昵称)

    #学习#、很好的`冂内容，学]习了。

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1203280, encodeId=3f0b1203280d6, content=学习了，非常感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b10a5123387, createdName=陈宪, createdTime=Wed Mar 16 22:47:00 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200245, encodeId=6d3312002454f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19a85577025, createdName=曾曾曾, createdTime=Mon Mar 07 15:52:55 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183846, encodeId=ef27118384638, content=感谢分享，大牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLPVlsekolw6geYQia4ibhibRsoaicSNwj85vxpvGKy4NVeFEAOw93Fpe5alWicWvia2ibVqlMlqkJ6Qnd7w/0, createdBy=b5442227668, createdName=单车, createdTime=Thu Jan 13 11:41:32 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075000, encodeId=3bf810e5000a3, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201127/23ff6f9b0b4d457488c4243a3bb0edac/c3674632650e47e5b3388daeb6015846.jpg, createdBy=7c7a5437558, createdName=ms4000002005061674, createdTime=Mon Nov 29 10:13:32 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1432183, encodeId=77a01432183ae, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sun Nov 07 07:56:46 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1455361, encodeId=5fae145536121, content=<a href='/topic/show?id=4272e0771a' target=_blank style='color:#2F92EE;'>#EULAR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7077, encryptionId=4272e0771a, topicName=EULAR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f855654200, createdName=muzishouyi, createdTime=Sun Nov 07 07:56:46 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067401, encodeId=69d8106e40178, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e99c5694546, createdName=ms3000001989507817, createdTime=Fri Nov 05 21:14:57 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067386, encodeId=e131106e3861b, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>、很好的`冂内容，学]习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1e52476457, createdName=1244b6b8m85(暂无昵称), createdTime=Fri Nov 05 20:07:28 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067351, encodeId=7968106e3519e, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644b2182796, createdName=1207866fm50(暂无昵称), createdTime=Fri Nov 05 18:52:21 CST 2021, time=2021-11-05, status=1, ipAttribution=)]
    2021-11-05 1207866fm50(暂无昵称)

    谢谢分享

    0

相关资讯

Clinica Chimica Acta：中国抗磷脂综合征患者非标准抗体的临床表现

越来越多的证据表明，非标准aPLs可在APS中作为现行标准aPLs的重要补充。在本研究中，研究人员评估了一组对磷脂抗原的非标准抗体，包括磷脂酰丝氨酸(aPS)、磷脂酰肌醇(aPI)、鞘磷脂(aSM)、磷脂酰胆碱(aPC)和磷脂酰乙醇胺(aPE)在明确的中国aPS队列中的临床表现。

张洋：抗磷脂综合征与心血管疾病

临床中，许多自身免疫疾病均有心脏等器官受累，心血管疾病是最常见的临床表现，对于心血管患者原发病的诊断和排除十分重要。

肝素诱导的血小板减少，你了解多少？

抗磷脂综合征（APS）的孕妇需要接受低分子肝素治疗，由于肝素有诱导血小板减少的副作用，同时APS本身也可以导致血小板减少，因此，当接受肝素治疗的APS患者发生血小板减少时需要鉴别究竟是疾病本身所致还是药物所致，这对于后续的治疗至关重要。本文主要对肝素诱导的血小板减少（HIT）及抗磷脂综合征的相关性以及二者的鉴别进行总结。

2019 抗磷脂综合征诊断和治疗共识

抗磷脂综合征（APS）为一种以反复动脉或者静脉血栓、病态妊娠和抗磷脂抗体（APL）持续阳性的疾病。本文主要针对抗磷脂综合症诊断和治疗的相关内容提出共识指导。

Arthritis Rheumatol：抗磷脂综合征的流行病学

每100,000人每年约有2人发生APS。估算患病率为每100,000人50例。总死亡率与一般人群没有差异。

产科抗磷脂综合征致妊娠晚期死胎5 例

抗磷脂综合征( antiphospholipid syndrome， APS) 是一种自 身免疫性疾病，以动静脉血栓形成、病理妊娠等症状为主要表 现，实验室检查患者血清中存在抗磷脂抗体( aPLs) ，包括狼疮 抗凝物( LA) 、抗心磷脂抗体( ACA) 和抗 β2 糖蛋白 － 1 抗体 ( β2-GP1) ［1］。产科抗磷脂综合征( obstetric APS， OAPS) 是指 以病理妊娠为